Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility – the second location for the privately held, New Jersey-headquartered customized clinical packaging provider.
This event runs from November 30 – December 1, 2016, in Seoul, Korea. Visit Xerimis at Booth #19.
Xerimis Inc. has been approved by the DEA as a registered distributor of schedule 3 through 5 controlled substances.
Xerimis Inc. is proud to announce that Carol Sue Bernardo, Executive Vice President, has been named Chief Executive Officer.